Hybrid Polysaccharide/Magnetite Microgels for Drug‐Free Magnetically Targeted Photothermal Thrombolysis
Advanced Healthcare Materials · 2026-03 · 15 (12)
DOI: 10.1002/adhm.202504603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 07.01.2026. Verfasst von Pierre Sarfati und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory For Vascular Translational Science (LVTS), Université Paris Cité, Université Sorbonne Paris Nord, UMR-S U1148 INSERM, Paris, France. Hauptthemen laut MEDLINE: Magnetite Nanoparticles, Polysaccharides, Thrombolytic Therapy, Photothermal Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: NAIVE-TF, Agence Nationale de la Recherche, ANR.
Abstract (Originalsprache)
Cardiovascular diseases are the leading cause of death worldwide, primarily due to ischemic events caused by thrombus formation, such as ischemic heart disease and stroke. Current treatments face significant limitations: mechanical thrombectomy lacks accessibility, while fibrinolytic drugs cause severe adverse effects and show limited efficacy. Local hyperthermia may offer a broader mechanism of action, targeting not only the fibrin scaffold but also other clot components. In this work, we present a fully drug‐free strategy based on hybrid microparticles (HPs) composed of magnetite nanoparticles (MNPs) assembled within cross‐linked dextran microgels, for magnetically targeted photo‐thermal therapy. HPs are synthesized through inverse emulsion cross‐linking using biocompatible materials. They exhibit micrometer injectable size, low dispersity, high colloidal stability and excellent biocompatibility. Magnetic coupling of ≈10 5 MNPs within each HP generates a strong magnetic macromoment (≈10 − 1 1 emu), enabling efficient magnetic targeting, both in vitro and in vivo. This feature is accompanied by high photo‐thermal conversion efficiency (38%). The determination of a thrombolytic temperature window enables in vitro photo‐thermal thrombolysis, while in vivo application on a murine thrombus model leads to significant photo‐thermal clot reduction (−32%), without any pharmaceutical agent. These findings highlight the potential of magnetically coupled magnetite nanoparticles for drug‐free targeted photo‐thermal thrombolysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory For Vascular Translational Science (LVTS), Université Paris Cité, Université Sorbonne Paris Nord, UMR-S U1148 INSERM, Paris, France.
- Université Paris Cité, UMS 34, Fédération de Recherche en Imagerie Multi-modalité (FRIM), Paris, France.
- Laboratoire Physique Des Cellules et Cancer, PCC, CNRS UMR168, Institut Curie, Sorbonne Université, PSL Research University, Paris, France.
- Département de Biophysique et de Médecine Nucléaire, Assistance Publique-Hôpitaux de Paris, Bobigny, France.
ORCID-Profile: Pierre Sarfati, Yoann Lalatonne, Cédric Chauvierre
Förderung
- NAIVE-TF
- Agence Nationale de la Recherche
- ANR
Zitieren
APA
Sarfati, P., de La Taille, T., Aid, R., Pavon-Djavid, G., Dos Santos, A., Mohammed, S., Amouroux, B., Clément, M., Wilhelm, C., Lalatonne, Y., & Chauvierre, C. (2026). Hybrid Polysaccharide/Magnetite Microgels for Drug‐Free Magnetically Targeted Photothermal Thrombolysis. Advanced Healthcare Materials, 15(12). https://doi.org/10.1002/adhm.202504603
Vancouver
Sarfati P, de La Taille T, Aid R, Pavon-Djavid G, Dos Santos A, Mohammed S, et al. Hybrid Polysaccharide/Magnetite Microgels for Drug‐Free Magnetically Targeted Photothermal Thrombolysis. Advanced Healthcare Materials. 2026;15(12). doi:10.1002/adhm.202504603
BibTeX
@article{Sarfati2026,
author = {Sarfati, Pierre and de La Taille, Thibault and Aid, Rachida and Pavon-Djavid, Graciela and Dos Santos, Adeline and Mohammed, Sofiane and Amouroux, Baptiste and Clément, Marc and Wilhelm, Claire and Lalatonne, Yoann and Chauvierre, Cédric},
title = {Hybrid Polysaccharide/Magnetite Microgels for Drug‐Free Magnetically Targeted Photothermal Thrombolysis},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {12},
doi = {10.1002/adhm.202504603}
}
EUVIMED